NASDAQ
VBIV

VBI Vaccines Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

VBI Vaccines Inc Stock Price

Vitals

Today's Low:
$0.6600
Today's High:
$0.7320
Open Price:
$0.7000
52W Low:
$0.63
52W High:
$3.42
Prev. Close:
$0.7115
Volume:
700974

Company Statistics

Market Cap.:
$0.184 billion
Book Value:
0.409
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-11321%
Gross Profit TTM:
$-0.010 billion
Gross Profit TTM:
$-0.010 billion
Profit Margin:
0%
Return on Assets TTM:
-23.5%
Return on Equity TTM:
-74.3%

Company Profile

VBI Vaccines Inc had its IPO on 1995-08-18 under the ticker symbol VBIV.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. VBI Vaccines Inc has a staff strength of 0 employees.

Stock update

Shares of VBI Vaccines Inc opened at $0.7 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.66 - $0.73, and closed at $0.66.

This is a -6.69% slip from the previous day's closing price.

A total volume of 700,974 shares were traded at the close of the day’s session.

In the last one week, shares of VBI Vaccines Inc have slipped by -33.61%.

VBI Vaccines Inc's Key Ratios

VBI Vaccines Inc has a market cap of $0.184 billion, indicating a price to book ratio of 1.776 and a price to sales ratio of 278.41.

In the last 12-months VBI Vaccines Inc’s revenue was $0.001 billion with a gross profit of $-0.010 billion and an EBITDA of $-0.073 billion. The EBITDA ratio measures VBI Vaccines Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, VBI Vaccines Inc’s operating margin was -11321% while its return on assets stood at -23.5% with a return of equity of -74.3%.

In Q2, VBI Vaccines Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 143.7%.

VBI Vaccines Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-0.286 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into VBI Vaccines Inc’s profitability.

VBI Vaccines Inc stock is trading at a EV to sales ratio of 209.61 and a EV to EBITDA ratio of -1.451. Its price to sales ratio in the trailing 12-months stood at 278.41.

VBI Vaccines Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

VBI Vaccines Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

VBI Vaccines Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

VBI Vaccines Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, VBI Vaccines Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, VBI Vaccines Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.66
52-Week High
$3.42
52-Week Low
$0.63
Analyst Target Price
$6

VBI Vaccines Inc stock is currently trading at $0.66 per share. It touched a 52-week high of $3.42 and a 52-week low of $3.42. Analysts tracking the stock have a 12-month average target price of $6.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About VBI Vaccines Inc

The stock symbol (also called stock or share ticker) of VBI Vaccines Inc is VBIV

The IPO of VBI Vaccines Inc took place on 1995-08-18

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$0.42
-0
-0.45%
$2.74
-0.02
-0.72%
Imv Inc (IMV)
$0.34
0.01
+3.23%
$3
0.1
+3.45%
$1.08
0
0%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company is headquartered in Cambridge, Massachusetts.

Address

222 THIRD STREET, SUITE 2241, CAMBRIDGE, MA, US